LEGACY'S FUTURE
- INNOVATIONS IN CREATION -
LEGACY was founded on the innovative concept of bringing high-end biotechnology to the consumer level, making it as common in households as toothpaste and televisions: Consumer Biologicals. These products will expand the once-limited field of applied biotechnology into the public sector, providing clients access to cutting-edge genetically engineered products. This is an endeavor that is preparing to test the limits of the imagination through a confrontation between what is technologically possible with what is commercially marketable on a global scale.
Our mission is to unapologetically question the self-imposed technological limitations we as a civilization constrain ourselves to, declaring that we are restricted only by our own fear of judgment and failure. In pushing through the boundaries we myopically perceive, we can reach technological heights that were only science fiction before. An unimaginably bright future lies in wait for those with the vision to join LEGACY’s mission.
In the years to come, LEGACY anticipates driving innovations in consumer-level applications such as:
-
Pets & Pet Products - a market $247 billion
-
Personal Care Products - a market $152 billion
-
Stationery - a market $3.9 billion
-
Artistry Media - a market $252 billion
-
Textiles - a market $646 billion
-
Plastic Production - a market of $625 billion
OUR IMMEDIATE OBJECTIVE
​
The flagship element within that goal has always been the fundamental intent to see the creation of synthetic bird- and reptile-based organisms using ancestral gene regression and novel genetic engineering. The development of these animals will represent a leap forward in what science is capable of, and with it, a profound paradigm the likes of which have not been seen in decades.
Additionally, LEGACY has a historic opportunity to leverage our own proprietary technologies toward an immediate de-extinction effort and the ecological restoration of a recently extinct species of bird. The revival of this species and others represents not only the groundwork for greater advances in the future, but will also prepare an eager consumer base for de-extinction-based ecotourism, introducing the public to creatures they otherwise would have only seen in museums.
LEGACY Biotheoretics stands to enter the commercial world exclusively unchallenged, driving revenues in excess of hundreds of millions of dollars conservatively within less than a decade, and establishing itself as a pioneer in its field, shifting the paradigm of what can be done through applied, consumer-level de-extinction and regenerative evolution biotechnology.
Vision
​​
​
​
Within the next decade, in the wake of an initial 18-24 month R&D period to develop our foundational research, the company will move rapidly towards a broad scale commercial roll-out, generating hundreds of millions of dollars within a decade. At that time, LEGACY will stand as an uncontested force in the field of Consumer Biologicals.
BY 2032, LEGACY WILL BE A $500+ MILLION COMPANY, WITH EACH NEW DEVELOPMENT ONLY INCREASING BRAND RECOGNITION, MARKET DOMINATION, AND CAPITAL RETURNS.
​
Like Microsoft, Amazon, and even Disney, we foresee LEGACY becoming a brand name recognized across the globe for its work in building a future of colorful dreams even when the world feels monochrome. We at LEGACY Biotheoretics can see what the future could be, and have the audacity to accept the challenge to bring it to pass.
Unbridled Ambition
​
LEGACY's goals are not just “ambitious ideas”. At the core level it sits at the crossroads of science, art, philosophy, and myth. We aren't just establishing a biotech sector. We're cracking open the boundaries of what humanity dares to believe it can touch: the ancient, the extinct, the lost chapters of the world’s story. We could’ve gone safe with traditional R&D, gene therapies, and biopharma. The route everyone else takes. But we didn't though, choosing instead to aim straight for the edge—the place where awe still lives.
No new frontier comes without risk, risk. Investors will raise brows, sure. Critics will scoff, certainly. Those are the people who always arrive late to revolutions. This is a company anchored to ambition, vision, and a lasting legacy of technological innovation, all of which are intricately woven into our quest to usher prehistory into the present, feather-by-feather, scale-by-scale, gene-by-gene.
"New ideas pass through three periods: 1) It can't be done. 2) It probably can be done, but it's not worth doing. 3) I knew it was a good idea all along!"
- Arthur C. Clarke -